Investment & Finance
New Data, New Players: Why Cannabis Pharma Deserves Investor Attention
Amid rising global scrutiny of the wider medical cannabis prescription model, and with markets like France leaning into pharmaceutical-grade regulation, the pharma cannabis sector is shaping up to be one of the most dynamic and closely watched corners of the industry.